Applied DNA Reports Third Quarter Fiscal 2022 Financial Results

Go back to Applied DNA Reports Third Quarter Fiscal 2022 Financial Results

Applied DNA Sciences (APDN) Tops Q3 EPS by 19c

August 11, 2022 4:14 PM EDT

Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.14 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

... More